✦ LIBER ✦

Myeloablative I-131-Tositumomab with Escalating Doses of Fludarabine and Autologous Hematopoietic Transplantation for Adults Age ≥ 60 Years with B Cell Lymphoma

✍ Scribed by Gopal, Ajay K.; Gooley, Ted A.; Rajendran, Joseph G.; Pagel, John M.; Fisher, Darrell R.; Maloney, David G.; Appelbaum, Frederick R.; Cassaday, Ryan D.; Shields, Andrew; Press, Oliver W.

Book ID: 122119914
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 420 KB
Volume: 20
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2014.02.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Trial of 131-Iodine Tositumomab

Phase II Trial of 131-Iodine Tositumomab with High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed Diffuse Large B Cell Lymphoma

✍ Vose, Julie M.; Bierman, Philip J.; Loberiza, Fausto R.; Enke, Charles; Hankins, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 324 KB

High-dose myeloablative therapy and auto

High-dose myeloablative therapy and autologous peripheral blood progenitor cell transplantation for elderly patients (greater than 65 years of age) with relapsed large cell lymphoma

✍ Jacob D Bitran; Leonard Klein; Doreen Link; Jane Kosirog-Glowacki; Cynthia Stewa 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Phase I study for poor-prognosis lymphom

Phase I study for poor-prognosis lymphoma: Augmentation of the “BEAM” regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation — a preliminary report

✍ G.L. Phillips II; C.N. Abboud; S.H. Bernstein; J.W. Friedberg; J.J. Ifthikharudd 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 82 KB